- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05255757
Network Interventions to Reduce Disparities in Living Kidney Donation
Social Network Interventions to Reduce Race Disparities in Living Kidney Donation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The overall goal is to understand the process and assist participants who do not receive unsolicited offers to be evaluated as a living kidney donor in initiating and effectively conducting these critical conversations with participants kin and friends. In the search intervention, based on what they can tell investigators about the number, type, perceived health, perceived relationship, and potential willingness to donate, as well as analyses of data from the National Health and Nutrition Examination Survey (NHANES) investigators will counsel them on which members of participants family and friendship networks appear most biomedically promising as donors among the subset of these individuals that participants have not ruled out for known medical or perceived relationship reasons. In the rhetorical intervention, investigators will test non-coercive, promising verbal scripts that have proven promising in preliminary tests in vignette experiments in online and phone surveys.
AIM 1: Survey transplant candidates about their social network and transplant-related attitudes, knowledge, and characteristics; and randomize participants into one of two interventions or a control group.
AIM 2: Send network member participants a survey that measures potential donor attributes that are hypothesized to influence donation decisions, such as medical contraindications, blood type, health insurance status, and barriers to living donation.
AIM 3: Test whether participant social networks and interventions affect donation outcomes using medical records and follow-ups provided by Penn and UAB. Investigators will create the first predictive model of potential donor evaluation and actual donation. This information is critical to improve clinical practice and efforts to ethically influence the living donor search process.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- University of Alabama-Birmingham
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Penn Medicine-- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Are KT candidates at the University of Pennsylvania or University of Alabama-Birmingham OR were identified by KT candidate from the University of Pennsylvania or University of Alabama-Birmingham as a network member
- Are adults aged 18 or older
- Are able and willing to consent to participation in the survey
Exclusion Criteria:
- Person is not a KT candidate at University of Pennsylvania or University of Alabama-Birmingham OR was NOT identified by KT candidate from University of Pennsylvania or University of Alabama-Birmingham as a network member
- Individuals who are not yet 18
- Participant does not speak English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No intervention
This group will only complete study survey and refer members of their family and social network for participation in a web survey.
|
|
|
Experimental: Script Intervention
This group will complete the survey, refer members of their family and social network for participation in a web survey, and review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network.
|
This intervention provides language to participants to allow them to discuss kidney transplantation with their social network.
|
|
Experimental: Search Intervention
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.
|
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.
|
|
Experimental: Both Search and Script Intervention
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation, and review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network.
|
This intervention provides language to participants to allow them to discuss kidney transplantation with their social network.
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Received a living donor kidney transplant
Time Frame: up to 3 years
|
Living donor kidney transplant received by patient
|
up to 3 years
|
|
Received a deceased donor kidney transplant
Time Frame: up to 3 years
|
Deceased donor kidney transplant received by patient
|
up to 3 years
|
|
Death
Time Frame: up to 3 years
|
Patient died during the follow-up period
|
up to 3 years
|
|
Completed living kidney donor screening questionnaires
Time Frame: up to 3 years
|
Number of completed living kidney donation screening questionnaires completed for patient
|
up to 3 years
|
|
Preliminary approval from living kidney donor screening questionnaires
Time Frame: up to 3 years
|
Number of completed living kidney donor screening that received preliminary approval for patient
|
up to 3 years
|
|
Completed living kidney donor evaluations
Time Frame: up to 3 years
|
Number of living kidney donor evaluations completed for patient
|
up to 3 years
|
|
Approvals for living kidney donor candidacy
Time Frame: up to 3 years
|
Number of completed living kidney donor evaluations that resulted in approved living kidney donor candidacy for patient
|
up to 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preference for living kidney donor
Time Frame: Immediate
|
A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding preference for living kidney donor
|
Immediate
|
|
Concerns about living kidney donation
Time Frame: Immediate
|
A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding concerns for living kidney donation
|
Immediate
|
|
Living donor kidney transplant willingness
Time Frame: Immediate
|
A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding living donor kidney transplant willingness
|
Immediate
|
|
Self-rated kidney transplant knowledge
Time Frame: Immediate
|
Respondent is asked to rate their level of knowledge related to kidney transplantation.
|
Immediate
|
|
Trust in medical institutions
Time Frame: Immediate
|
Respondent is asked to rate their trust in medical institutions.
|
Immediate
|
|
Religious views' effect on kidney transplant willingness
Time Frame: Immediate
|
Respondent is asked how strongly they agree that their religious views affect their willingness to pursue a kidney transplant.
|
Immediate
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 849197
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End-stage Renal Disease
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
University of Illinois at ChicagoWithdrawnObesity | End-Stage Renal Disease | Renal Disease, End-Stage | Renal Failure, End-StageUnited States
-
Bioconnect Systems, IncCompletedEnd-stage Renal Disease | End-stage Kidney DiseaseUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalMcGill University Health Centre/Research Institute of the McGill University...Not yet recruitingEnd Stage Renal Disease on Dialysis
-
Suzhou Alphamab Co., Ltd.RecruitingEnd-Stage Renal Disease Requiring HaemodialysisChina
-
Tuen Mun HospitalEnrolling by invitationDialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis (DETECT-PD)Peritoneal Dialysis | End-Stage Kidney Disease | End Stage Renal Disease (ESRD) | End Stage Renal Failure on Dialysis | Peritoneal Dialysis Patients | End Stage Renal Disease on Dialysis (Diagnosis)Hong Kong
-
Chang Gung Memorial HospitalRecruitingPhysical Fitness/Training and Inflammatory Immune Responses in Patients With End-stage Renal DiseaseEnd-stage Renal DiseaseTaiwan
-
Lawson Health Research InstituteCompletedEnd-Stage Renal DiseaseCanada
-
Vanderbilt UniversityWithdrawnEnd-Stage Renal DiseaseUnited States
Clinical Trials on Script Intervention
-
University of Texas at AustinHospital Clinic of Barcelona; Fundació Institut de Recerca de l'Hospital de...RecruitingNeurocognitive Disorders | Neurodegenerative Diseases | Dementia | Alzheimer Disease | Language Disorders | Communication Disorders | Primary Progressive Aphasia | Aphasia | Speech Disorders | Frontotemporal Lobar Degeneration | Dysarthria | Apraxia, Motor | Dementia, Frontotemporal | Bilingual AphasiaSpain, United States
-
NYU Langone HealthCompletedAnnual Visit, Well VisitUnited States
-
The Hong Kong Polytechnic UniversityJohns Hopkins University; Prof FONG NAI KUEN KENNETH; Dr LI SHI PUI; Dr NG HIU...Not yet recruitingAphasia, Acquired | Chronic Stroke
-
The Hong Kong Polytechnic UniversityActive, not recruiting
-
Central Hospital, Nancy, FranceUnknownVascular Access Site PainFrance
-
Shirley Ryan AbilityLabUniversity of Colorado, BoulderCompleted
-
University College CorkUnknownAppropriateness of Prescribing in Older PatientsIreland
-
Shirley Ryan AbilityLabNorthwestern University; National Institute on Deafness and Other Communication... and other collaboratorsCompleted
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)Completed
-
Emory UniversityCompletedChronic Inflammatory Skin DiseasesUnited States